TY - JOUR
T1 - Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IκBα overexpression
AU - Sumitomo, Makoto
AU - Tachibana, Masaaki
AU - Ozu, Choichiro
AU - Asakura, Hirotaka
AU - Murai, Masaru
AU - Hayakawa, Masamichi
AU - Nakamura, Hiroshi
AU - Takayanagi, Atsushi
AU - Shimizu, Nobuyoshi
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1999/1/1
Y1 - 1999/1/1
N2 - We investigated whether the cell growth and apoptosis of multiple cytokine-producing bladder cancer cells can be regulated by nuclear factor κB (NF-κB). The bladder cancer cell line KU-19-19, obtained from a 76-year-old man who demonstrated marked leukocytosis, produces multiple cytokines and demonstrates autocrine growth by granulocyte colony-stimulating factor (G-CSF). Electrophoretic mobility shift assay (EMSA) revealed that NF-κB was activated in KU-19-19 but not in other bladder cancer cell lines (KU-1, KU-7, or T-24, respectively). The inhibition of NF-κB DNA-binding activity with adenovirus vectors expressing the stable form of the NF-κB inhibitor IκBα (multiplicity of infection [MOI] of 10) inhibited growth and induced apoptosis of KU-19-19, but not KU-1, KU-7, or T-24. The production of several cytokines was suppressed significantly in KU-19-19 by this gene delivery. Although dexamethasone (10 μM) could also suppress cytokine production, it did not induce dramatic cell death in KU-19-19 because it could not inhibit NF-κB activation stably and strongly. These results suggest that NF-κB activation maintains the cell viability as well as regulates cytokine production in cytokine-producing cancer cells and therefore these in vitro experiments support a rationale for preclinical in vivo studies to demonstrate growth inhibition in established tumors.
AB - We investigated whether the cell growth and apoptosis of multiple cytokine-producing bladder cancer cells can be regulated by nuclear factor κB (NF-κB). The bladder cancer cell line KU-19-19, obtained from a 76-year-old man who demonstrated marked leukocytosis, produces multiple cytokines and demonstrates autocrine growth by granulocyte colony-stimulating factor (G-CSF). Electrophoretic mobility shift assay (EMSA) revealed that NF-κB was activated in KU-19-19 but not in other bladder cancer cell lines (KU-1, KU-7, or T-24, respectively). The inhibition of NF-κB DNA-binding activity with adenovirus vectors expressing the stable form of the NF-κB inhibitor IκBα (multiplicity of infection [MOI] of 10) inhibited growth and induced apoptosis of KU-19-19, but not KU-1, KU-7, or T-24. The production of several cytokines was suppressed significantly in KU-19-19 by this gene delivery. Although dexamethasone (10 μM) could also suppress cytokine production, it did not induce dramatic cell death in KU-19-19 because it could not inhibit NF-κB activation stably and strongly. These results suggest that NF-κB activation maintains the cell viability as well as regulates cytokine production in cytokine-producing cancer cells and therefore these in vitro experiments support a rationale for preclinical in vivo studies to demonstrate growth inhibition in established tumors.
UR - http://www.scopus.com/inward/record.url?scp=0032961680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032961680&partnerID=8YFLogxK
U2 - 10.1089/10430349950019174
DO - 10.1089/10430349950019174
M3 - Article
C2 - 10022529
AN - SCOPUS:0032961680
SN - 1043-0342
VL - 10
SP - 37
EP - 47
JO - Human Gene Therapy
JF - Human Gene Therapy
IS - 1
ER -